WHH USA is the premier summit for the most influential leaders, innovators, and changemakers shaping the future of women’s health. Curated for maximum impact, WHH USA convenes bold executives, investors, clinicians, and policymakers to tackle the urgent challenges defining women’s health in 2025 and beyond. This is where innovation accelerates, policy shifts, and new solutions...
San Diego | October 15, 2025 | Fairmont Grand Del Mar We would like to extend a personal invitation for you to attend Biocom California’s third annual life sciences industry CEO Summit for the San Diego region, which will be held in-person on October 15, at Fairmont Grand Del Mar located on 400 acres alongside...
Wine Country | October 24, 2025 | Ram’s Gate Winery We would like to extend a personal invitation for you to attend Biocom California’s fifth annual life science CEO Summit for the Northern California region. This in-person event will be held on Friday, October 24 at Ram’s Gate Winery, conveniently located at the southern edge...
The 4th annual Chief Commercial Officer Summit highlights the vision and direction you need for driving commercial growth and excellence. Our all-new agenda helps you build the skills and business acumen to implement strategic, tactical and operational plans for advancing access and propelling commercial growth. This is a tremendous opportunity to join leading commercial executives...
BIO on the BAYOU is a pivotal showcase of underrepresented yet burgeoning biotech and health-related research emerging from universities and small companies in the broader Gulf South. Despite the region's historical challenges with limited resources and restricted industry and investor capital access, BIO on the BAYOU serves as the catalyst for regional change agents to...
Los Angeles | October 29, 2025 | Luxe Sunset Boulevard Hotel We would like to extend a personal invitation for you to attend Biocom California’s eighth annual life sciences industry CEO Summit for the Greater Los Angeles region, which will be held in-person on October 29, at the Luxe Sunset Hotel located between Westwood and...
From 17 to 20 November 2025, MEDICA will once again gather international experts from the medical industry in Düsseldorf, Germany. With over 5,000 exhibitors from 72 countries and 80,000 visitors MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. It offers a central stage for innovative products and services from the fields of medical imaging, laboratory...
Optimize Your Gross-To-Net Strategies to Drive Financial Excellence Save 10% today with VIP code: 25B4B10* The Pharma/Biotech GTN Summit, taking place November 18-20, 2025 in Philadelphia, PA, is a CPE accredited conference designed to equip pharmaceutical and biotech finance professionals with proven methodologies, forecasting models, and automation insights to enhance visibility, profitability, and control in gross-to-net management. Whether your organization is...
This congress is designed to help educate and share innovative program design, latest customer strategies and practical solutions to overcome complex barriers, enhance program performance and deliver best-in-class patient programs amidst evolving regulations. Compliance and Operations teams unite at Patient Support Services Congress for next-level benchmarking to drive program success. Benefit from collaborative sessions as...
Greater Philadelphia sits at the forefront of a dynamic life sciences evolution, where strategic decision-making today will shape the trajectory of the region’s biotech and innovation economy for years to come. As funding landscapes shift, groundbreaking research emerges, and tenant demands evolve, stakeholders across commercial real estate, including developers, investors, and brokers, need critical insights...
What You'll Learn: How will lower interest rates influence biotech funding, investment flows, and real estate capital allocation in 2025? With a record volume of new lab and GMP supply delivering this year, how can owners make their assets stand out in a crowded market? Is renewed activity in biotech IPOs and venture funding a...
